Tirzepatide 15mg — Vial Spec, Reconstitution Math & COA
A 15mg lyophilized vial of tirzepatide offers high-yield unit capacity specifically formulated for extended preclinical research, multi-well cell culture assays, and high-throughput analytical modeling. This technical guide outlines chemical specifications, volume reconstitution math across standard laboratory diluent ratios, aliquot planning, and lot-matched analytical verification provided by PX1 Research.
Quick answer
A 15mg lyophilized vial of tirzepatide offers high-yield unit capacity specifically formulated for extended preclinical research, multi-well cell culture assays, and high-throughput analytical modeling. This technical guide outlines chemical specifications, volume reconstitution math across standard laboratory diluent ratios, aliquot planning, and lot-matched analytical verification provided by PX1 Research.
Key takeaways
- In laboratory research environments, a 15mg vial of [tirzepatide](/research-peptides/tirzepatide) represents a high-density cake of lyophilized peptide designed for multi-dosing rodent assays or high-concentration in vitro receptor binding studies.
- Preclinical studies indicate that [tirzepatide](/research-peptides/tirzepatide) functions as an imbalanced dual agonist, exhibiting equal potency to native GIP at the GIP receptor while demonstrating approximately five-fold lower potency than native GLP-1 at the GLP-1 receptor.
- Accurate reconstitution math is vital when translating raw peptide mass into precise working concentrations (µg/µL or mg/mL).
- Repeated freeze-thaw cycles lead to peptide aggregation, peptide bond cleavage, and loss of functional potency in receptor binding assays.
Tirzepatide 15mg Mass Specification & Laboratory Context
In laboratory research environments, a 15mg vial of tirzepatide represents a high-density cake of lyophilized peptide designed for multi-dosing rodent assays or high-concentration in vitro receptor binding studies. Tirzepatide is a synthetic 39-amino-acid peptide engineered to display dual agonism against the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Ordering a 15mg mass allocation allows research teams to prepare uniform stock solutions that service broad test cohorts without introducing inter-vial reconstitution variability.
When managing research projects requiring continuous administration or multi-plate assays, selecting a 15mg format reduces the frequency of handling individual vials, minimizing contamination vectors and baseline instrument recalibrations. At PX1 Research, peptides are synthesized under strict quality controls and packaged under inert argon environments to prevent oxidative degradation. Investigators looking for high-purity dual agonists can inspect our complete inventory via the research peptide catalog or review specific compound specifications such as tirzepatide research formats.
Dual GIP and GLP-1 Receptor Agonism Mechanism of Action
Preclinical studies indicate that tirzepatide functions as an imbalanced dual agonist, exhibiting equal potency to native GIP at the GIP receptor while demonstrating approximately five-fold lower potency than native GLP-1 at the GLP-1 receptor. The primary sequence incorporates a C20 fatty di-acid chain linked via a gamma-glutamic acid spacer, which promotes reversible binding to albumin in laboratory assays. This structural modification extends the peptide's terminal elimination half-life in rodent models to approximately 5 days, enabling sustained receptor activation across extended observation windows.
In vitro signaling assays show that activation of both GIP and GLP-1 receptors synergistically stimulates cyclic adenosine monophosphate (cAMP) accumulation in cell lines expressing recombinant human or rodent receptors. In rodent models of metabolic dysregulation, co-activation of GIP and GLP-1 pathways has been observed to modulate central appetite centers in the hypothalamus, enhance glucose-dependent insulin secretion, and improve peripheral insulin sensitivity to a greater extent than selective GLP-1 receptor single agonists.
Reconstitution Math & Diluent Volume Configurations for 15mg
Accurate reconstitution math is vital when translating raw peptide mass into precise working concentrations (µg/µL or mg/mL). The formula for determining stock concentration ($C$) based on total mass ($m = 15\text{ mg}$) and added diluent volume ($V$) is defined as $C = m / V$. Depending on micro-pipette limits, microfluidic delivery systems, or assay volume constraints, researchers typically utilize 1.0 mL, 2.0 mL, or 3.0 mL of sterile bacteriostatic water (0.9% benzyl alcohol) or sterile normal saline.
When 1.0 mL of diluent is introduced into a 15mg vial, the resulting final concentration is exactly 15.0 mg/mL (15.0 µg/µL). This high-density stock is ideal for low-volume micro-injection setups or automated dispensing robotics. Introducing 2.0 mL of diluent yields a concentration of 7.5 mg/mL (7.5 µg/µL), providing an optimal balance between fluid handling accuracy and volume preservation. Diluting with 3.0 mL of diluent results in a concentration of 5.0 mg/mL (5.0 µg/µL), which simplifies aliquot volume calculations for larger test groups. Researchers can perform rapid custom volumetric conversions using the PX1 interactive reconstitution calculator.
Micro-Aliquot Planning and Volumetric Precision
Repeated freeze-thaw cycles lead to peptide aggregation, peptide bond cleavage, and loss of functional potency in receptor binding assays. To maintain peptide integrity following the reconstitution of a 15mg vial, laboratories should immediately subdivide the master solution into single-use micro-aliquots using sterile, low-binding polypropylene micro-centrifuge tubes.
For example, a 15mg vial reconstituted in 3.0 mL of diluent (5.0 mg/mL concentration) can be partitioned into fifteen 200 µL aliquots, each containing 1.0 mg of working compound, or thirty 100 µL aliquots containing 500 µg each. Aliquots designated for immediate use within 48 to 72 hours should be maintained at 2°C to 8°C, while long-term experimental reserves must be flash-frozen and stored at -20°C or -80°C. Avoiding glass storage for diluted working solutions reduces non-specific surface adsorption of the hydrophobic peptide sequence.
Comparative Analysis: Tirzepatide vs. Semaglutide, Retatrutide, and Liraglutide
Within preclinical metabolic and incretin research, evaluating structural and pharmacodynamic differences across single, dual, and triple receptor agonists is a critical objective. Single-target GLP-1 receptor agonists such as semaglutide research compounds and earlier generation agents like liraglutide preclinical models engage only the GLP-1 receptor pathway, offering benchmark data for isolated incretin signaling.
Conversely, tirzepatide integrates dual GIP/GLP-1 agonism to evaluate cross-pathway metabolic synergy. Next-generation multi-agonist research also examines triple agonists like retatrutide analytical compounds, which incorporate glucagon receptor activity alongside GIP and GLP-1 targets. In comparative rodent assays, dual and triple targeting agents consistently demonstrate superior modulation of energy expenditure, lipid oxidation, and glycemic control compared to mono-agonists, establishing tirzepatide as an indispensable comparative standard in receptor cross-talk studies.
Chemical Stability, Lyophilization Matrix, and Temperature Control
Tirzepatide is supplied as a lyophilized white powder composed of the active peptide monomer alongside inert excipients (such as mannitol or trehalose) designed to maintain structural cake integrity during freeze-drying. In its dry, lyophilized state, tirzepatide exhibits high chemical stability when stored away from direct light at -20°C, maintaining purity standards for up to 24 months.
Exposure to elevated ambient temperatures, high humidity, or direct ultraviolet radiation can induce deamidation of susceptible amino acid residues or hydrolysis of the peptide backbone. Once reconstituted, the liquid solution exhibits limited stability. Bacteriostatic diluents inhibit microbial growth for up to 28 days under refrigeration (2°C to 8°C), but thermal degradation and structural unfolding gradually accelerate after 14 days. Researchers are advised to perform baseline high-performance liquid chromatography (HPLC) checks if reconstituted stock solutions are stored beyond standard operational windows.
ISO 17025 Lot-Matched COA Verification & HPLC/MS Analysis
To ensure rigor and reproducibility in scientific experiments, PX1 Research subjects every production lot of tirzepatide to comprehensive third-party testing in an ISO 17025 accredited laboratory. Each batch is accompanied by a lot-matched Certificate of Analysis detailing high-performance liquid chromatography (HPLC) chromatograms and mass spectrometry (MS) spectra.
HPLC analysis verifies chemical purity—consistently exceeding 99.0%—by resolving potential synthesis impurities, truncated sequences, or protective group artifacts. Electrospray ionization mass spectrometry (ESI-MS) or MALDI-TOF confirms exact molecular mass matching the theoretical formula of tirzepatide (4813.5 Da). Furthermore, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below <0.01 EU/mg, preventing confounding inflammatory responses in cell cultures or animal models. Laboratory teams can access verified documentation at any time through our COA lookup database.
Mass Selection Guide: When to Choose 5mg, 10mg, or 15mg Vials
Choosing the appropriate vial mass depends on protocol duration, sample size, and reagent preservation goals. While a 5mg or 10mg vial is optimal for preliminary pilot studies, single-cell assays, or brief dose-response calibrations, the 15mg vial format is preferred for continuous, large-scale preclinical studies.
Using a single 15mg vial rather than multiple smaller vials reduces unit-to-unit handling steps, lowers overall shipping and storage overhead, and ensures uniform concentration across broad test groups. However, if an assay requires only small, sporadic doses over several months, smaller vial sizes may be preferable to minimize the storage duration of reconstituted liquid stock. Detailed research literature and compound background can be explored further in the PX1 peptide research hub.
Laboratory Standard Operating SOP: Aseptic Reconstitution Technique
To preserve sterile integrity and avoid peptide shear stress during reconstitution, research personnel should follow a standardized laboratory protocol inside a certified Class II laminar flow hood:
1. Sanitize the vial stopper and diluent ampoule using 70% isopropyl alcohol wipes and allow them to air-dry fully. 2. Using a sterile syringe fitted with a 21G–25G needle, draw the exact pre-calculated volume of diluent (e.g., 2.0 mL of bacteriostatic water). 3. Position the needle tip against the internal glass wall of the tirzepatide vial and slowly depress the plunger, allowing the fluid to stream down the glass rather than spraying directly onto the lyophilized cake. 4. Allow the vacuum pressure inside the vial to equalize naturally before withdrawing the needle. 5. Gently swirl the vial in a smooth circular motion until the lyophilized powder is completely dissolved. Never vortex or vigorously shake the vial, as mechanical agitation causes surface denaturation and structural foaming.
Institutional Sourcing & PX1 Quality Assurance Standards
PX1 Research is dedicated to supplying North American research institutions, university laboratories, and private biotechnology firms with premium, domestic research compounds. All peptides are synthesized in USA-based, GMP-compliant facilities and undergo stringent batch testing prior to release.
Orders ship directly from specialized distribution facilities in California and Arizona, with same-day processing available Monday through Friday. High-volume laboratories and institutional procurement managers requiring bulk allocations or ongoing research supplies can establish tailored delivery schedules through PX1 wholesale lab accounts.
Frequently Asked Questions
What is the resulting concentration when reconstituting a 15mg tirzepatide vial with 2mL of diluent?
Reconstituting a 15mg lyophilized vial with 2.0 mL of diluent yields a final stock concentration of exactly 7.5 mg/mL (7.5 µg/µL).
How does PX1 Research verify the purity and identity of Tirzepatide 15mg?
Every lot undergoes independent third-party testing in ISO 17025 accredited facilities. Purity is verified (>99.0%) via High-Performance Liquid Chromatography (HPLC), identity is confirmed via Mass Spectrometry (MS), and safety is validated via LAL endotoxin testing (<0.01 EU/mg).
Can reconstituted tirzepatide 15mg be frozen for long-term storage?
Reconstituted liquid stock can be micro-aliquoted into single-use polypropylene tubes and stored at -20°C or -80°C to prevent degradation. Repeated freeze-thaw cycles must be strictly avoided to prevent peptide aggregation.
What diluent is recommended for laboratory reconstitution of tirzepatide?
Sterile bacteriostatic water (0.9% benzyl alcohol) is recommended for multi-use working solutions stored up to 28 days under refrigeration. For immediate single-assay applications, sterile 0.9% sodium chloride (normal saline) may also be utilized.
Why is high mass allocation (15mg) advantageous for animal model studies?
A 15mg mass allocation allows researchers to prepare larger master batches, ensuring consistent solution concentration across extensive rodent cohorts while minimizing inter-vial reconstitution variance.
What receptors are targeted by tirzepatide in preclinical models?
Tirzepatide acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor.
What is the endotoxin limit for PX1 tirzepatide research lots?
PX1 Research enforces a strict endotoxin threshold of less than 0.01 EU/mg for all lot-certified research compounds, preventing confounding immune or inflammatory artifacts in cell culture and animal models.
How can researchers access the Certificate of Analysis (COA) for their specific vial?
Lot-matched COAs can be downloaded directly from the PX1 online COA database by entering the batch number printed on the vial label.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.